Deal making is the lifeblood of the pharmaceutical sector. In- and out-licensing and other types of agreements are key mechanisms by which intellectual property (IP) of innovative products and technologies is transferred between companies for achievement of development and commercialisation objectives. It is vital that companies execute good deals as this underpins their future profitability, drives share price and demonstrates management competency.

Understanding Headline Deal Values A PharmaVentures Guide to the Interpretation of Deal Terms and Terminology

Download Request